Atrioventricular conduction after alcohol septal ablation for obstructive hypertrophic cardiomyopathy

Anna Axelsson1, Kristina Weibring, Ole Havndrup

  • 1aDepartment of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet & The University of Copenhagen bDepartment of Cardiology, Roskilde Sygehus, Roskilde, Denmark.

Insights

Alcohol septal ablation for hypertrophic cardiomyopathy can cause heart block. Some patients experience normalized heart conduction years later, particularly those without baseline PR interval prolongation or acute heart block during the procedure.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Interventions

Background:

  • Alcohol septal ablation (ASA) is used for obstructive hypertrophic cardiomyopathy (HCM).
  • Atrioventricular (AV) conduction system damage is a known complication of ASA.
  • Long-term outcomes of AV conduction after ASA require further investigation.

Purpose of the Study:

  • To assess long-term atrioventricular conduction in patients following alcohol septal ablation.
  • To identify predictors of persistent atrioventricular block after ASA.

Main Methods:

  • Prospective ECG and Holter monitoring in pacemaker patients post-ASA.
  • Retrospective analysis of AV conduction in non-pacemaker patients.
  • Comparison of baseline characteristics between patients with and without persistent AV block.

Main Results:

  • 28% of patients developed high-grade AV block requiring pacemakers after ASA.
  • In 14 pacemaker patients followed long-term (mean 6.2 years), 6 showed normalized AV conduction.
  • Baseline PR interval ≥200ms and acute complete heart block during ASA predicted higher risk of persistent AV block.

Conclusions:

  • Long-term recovery of AV conduction is possible in some patients after ASA.
  • Baseline PR interval and acute procedural events are crucial in predicting persistent AV block.
  • ASA requires careful consideration of AV conduction risks in obstructive HCM patients.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
788
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460